Protest banners appeared throughout Tbilisi early in the morning ... PSP, one of Georgia’s major pharmaceutical companies and a pharmacy chain, participated in a symbolic five-minute strike. Company ...
Perhaps the first time in history, timed with the inauguration, the Mothers Movement of Sri Lanka decided to converge outside ...
Robert F. Kennedy attempted Thursday to score a cheap political point against Senator Bernie Sanders by accusing the ...
The Federal Aviation Administration’s preliminary report on the D.C. plane crash goes against everything the president has ...
CAMBRIDGE, England & BOSTON, January 13, 2025--(BUSINESS WIRE)--Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which ...
Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM (monomethyl fumarate) product for the treatment ...
The judge said that the farmers, whose land was being acquired, could not be deprived of their right to protest and organise events opposing the establishment of pharma city or any other project ...
Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda ...
Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM ® (monomethyl fumarate) product for the ...
Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...
The growing investment in India's CDMO sector indicates confidence in India’s pharmaceutical sector and its potential - A detailed analysis. With the U.S. increasingly adopting an anti-China ...
Novo Nordisk, for its part, is expected to jump from 10th place to sixth this year, according to Evaluate Pharma’s consensus forecasts. Nevertheless, it’s Roche that’s been tipped to stand ...